Home > what is IVI> Introduction
Vision & Mission 
 
 
Vision & Mission
   
• Vision
  The International Vaccine Institute is founded on the belief that health in developing countries can be dramatically improved by the development, introduction and use of new and improved vaccines and that these vaccines should be developed through a dynamic interaction among science, public health, and business. The IVI will be a center of science for the public interest where this dynamic interaction can take place through research, training, technical assistance, service provision, and information dissemination.
   
• Mission
  The International Vaccine Institute will contribute to the reduction of vaccine preventable diseases in developing countries by collaborative research that generates the evidence needed for rational introduction of new vaccines, supported by programs of basic and applied laboratory research, product development, training, and technical assistance.
   
 
The IVI and the Millennium Development Goals
 
At the United Nations Millennium Summit in September 2000 world leaders placed development at the heart of the global agenda by adopting the Millennium Development Goals (MDGs), which set clear targets for reducing poverty, hunger, disease, illiteracy, environmental degradation, and discrimination against women by 2015. The eight Millennium Development Goals constitute an ambitious agenda to significantly improve the human condition by 2015. The IVI is actively working to make a valuable contribution to achieving the MDGs. IVI's work supports the following three MDGs:
 
Millennium Development Goal 1, "Eradicate extreme poverty and hunger". By preventing unnecessary deaths and allowing people, especially children, to lead healthy lives, the IVI contributes to alleviating poverty and strengthening economies.
 
Millennium Development Goal 4, "Reduce child mortality". The research programs at the IVI contribute to the target of reducing by two-thirds, between 1990 and 2015, the under-five mortality rate by addressing new-generation vaccines against diarrhea and respiratory infections, and against Japanese encephalitis and dengue fever. Together these diseases claim the lives of nearly five million persons each year, most of whom are children living in impoverished conditions in developing countries.
 
Millennium Development Goal 6, "Combat HIV/AID, malaria and other diseases". The research programs at the IVI contribute to the target of reducing by two-thirds, between 1990 and 2015, the under-five mortality rate by accelerating the introduction of new-generation vaccines against diarrhea and respiratory infections, and against Japanese encephalitis and dengue fever. Together these diseases claim the lives of over four million persons each year, most of whom are children living in impoverished conditions in developing countries.
 
Millennium Development Goal 8, "Develop a global partnership for development". The mission of the IVI is to develop and accelerate the introduction of new vaccines at affordable prices into the public-health programs of developing countries. The IVI facilitates transfer of vaccine technology to pharmaceutical companies in developing countries to create cost-effective vaccines for the world's poor. The Institute also provides training and technical assistance for the clinical evaluation of vaccines and vaccine production and regulation to professionals in developing countries.